ORAPRED ODT
LOE Approachingprednisolone sodium phosphate
NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Jun 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
properties. Some of these properties reproduce the physiological actions of endogenous glucocorticosteroids, but others do not necessarily reflect any of the adrenal hormones' normal functions; they are seen only after administration of large therapeutic doses of the drug. The pharmacological…
Indications (22)
the treatment of the following diseasesconditions: Orapred ODT is a corticosteroid indicatedimmunosuppressive agent for certain allergicdermatologicgastrointestinalhematologicophthalmologicnervous systemrenalrespiratoryrheumatologicspecific infectious diseasesconditionsorgan transplantation () for the treatment of certain endocrine conditions () for palliation of certain neoplastic conditions () 1Atopic dermatitisCrohn's DiseaseUlcerative colitismultiple sclerosischronic obstructive pulmonary diseaseCOPDAsthmaRheumatoid arthritis